Research and Markets (http://www.researchandmarkets.com/research/dh7gkz/pollen) has announced the addition of the "Pollen Allergy-Pipeline Insights, 2016" report to their offering.
Pollen Allergy Infection-Pipeline Insights, 2016 provides in depth insights on the pipeline drugs and their development activities around the Pollen Allergy Infection. The report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration.
Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details.
The report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Pollen Allergy Infection.
The report also assesses the Pollen Allergy Infection therapeutics by Monotherapy, Combination products, molecule type and Route of Administration.
Scope
- The report provides competitive pipeline landscape of Pollen Allergy Infection
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Pollen Allergy Infection pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Pollen Allergy Infection and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type
Key Topics Covered:
- Pollen Allergy Infection Overview
- Pollen Allergy Infection Pipeline Therapeutics
- Pollen Allergy Infection Therapeutics under Development by Companies
- Pollen Allergy Infection Filed and Phase III Products
- Comparative Analysis
- Pollen Allergy Infection Phase II Products
- Comparative Analysis
- Pollen Allergy Infection Phase I and IND Filed Products
- Comparative Analysis
- Pollen Allergy Infection Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Pollen Allergy Infection - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Pollen Allergy Infection - Discontinued Products
- Pollen Allergy Infection - Dormant Products
- Companies Involved in Therapeutics Development for Pollen Allergy Infection
For more information visit http://www.researchandmarkets.com/research/dh7gkz/pollen
View source version on businesswire.com: http://www.businesswire.com/news/home/20160118005670/en/